KARTIKEYA SOLUTIONS LIMITED

Company number 05603295 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Score: A

Explanation: Kartikeya Solutions Limited is in excellent financial condition, exhibiting the vital signs of a highly robust and thriving business. The company boasts an exceptionally strong liquidity position, minimal debt, and consistent year-on-year growth in net assets. While the most recent profit figures include a significant non-cash property revaluation, the underlying operational heartbeat remains very healthy.


Key Vital Signs

1. Blood Pressure (Liquidity & Cash Flow) * Current Ratio: 6.3x (£1.91M current assets / £302k current liabilities) * Cash Reserves: £1.36M * Interpretation: The company's financial blood pressure is remarkably stable. With £6.33 in current assets for every £1 of short-term debt, the business has absolutely no trouble meeting its immediate obligations. The robust cash reserves mean the company is highly liquid and not reliant on external financing to keep the blood pumping through day-to-day operations.

2. Heartbeat (Profitability) * Reported Profit: £1,065,054 * Underlying Operational Profit: ~£375,475 * Interpretation: The reported profit shows a strong heartbeat, but a closer listen reveals a slight murmur. Over £689,000 of this profit comes from a non-cash revaluation gain on an investment property (moving from £0 to £1.4M on the balance sheet). While this fair value adjustment is a genuine boost to overall wealth, the underlying operational profit of approximately £375k is still a very healthy pulse for a company of this size, especially considering the £135,000 dividend payout.

3. Cholesterol (Debt Levels) * Total Liabilities: £532k (Current: £302k + Provisions: £229k) * Bank Loans: £94,726 * Interpretation: The company has very little "bad cholesterol" (debt). Bank loans are modest and falling (down from £129k the previous year), and trade creditors are normal operational debts. The business is not clogging its arteries with expensive or excessive third-party debt.

4. Muscle Mass (Asset Growth) * Net Assets Growth: From £414k (2016) to £2.79M (2025) * Interpretation: The company has consistently built its financial muscle over the last decade. Net assets have grown nearly sevenfold in ten years, showing a sustained ability to generate and retain wealth.


Diagnosis

The patient is in peak physical condition, displaying the financial equivalent of excellent cardiovascular health and strong immunity. The business has successfully transitioned from holding standard fixed assets (freehold property) to an investment property model, resulting in a substantial £1.4M asset on the books that provides both capital appreciation and (presumably) rental income.

However, the diagnostic scan reveals two minor symptoms that require monitoring: 1. Related Party Arterial Plaque: £351,860 is owed by a related party. While this is common in privately held companies, it represents a significant portion of current assets. If this "loan" is not on strict repayment terms, it could restrict healthy cash flow circulation. 2. Latent Provision: A new provision for liabilities of £229,860 has appeared on the balance sheet. This is a latent symptom—like a minor cyst—that needs a clear diagnosis. It could be for expected future costs (like a tax liability or legal settlement) and represents a potential future drain on resources.


Recommendations

  1. Monitor Related Party Lending: Treat the £351k related party debtor as a priority. Ensure this amount is on a formal, interest-bearing repayment schedule. Leaving such a large amount of capital tied up outside the core business limits your financial flexibility.
  2. Investigate the Provision: Conduct a thorough examination of the £229k provision. Understanding exactly what this liability is for will ensure there are no unexpected financial hemorrhages in the coming year.
  3. Strategic Cash Deployment: With £1.36M sitting in cash, the company is holding more liquidity than it strictly needs for a rainy day. Consider whether this "financial fat" could be better deployed—either through higher-yield investment, further property acquisition, or returning a greater portion to shareholders via dividends, rather than letting inflation erode its purchasing power.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 11 August 2026